Search Within

Qing-Bai She

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (9)
Groups
  1. Department of Medicine (25)
  2. GSK Faculty (25)
  3. Human Oncology and Pathogenesis Program (25)
  4. Solid Tumor Oncology Division (25)
  5. Sloan Kettering Institute Faculty (24)
  6. Breast Medicine Service (23)

More Groups

People
  1. Neal Rosen (23)
  2. David Solit (20)
  3. Qing Ye (14)
  4. Kathryn O'reilly (5)
  5. Jose Lobo (4)
  6. Manickam Janakiraman (4)

More People

Years
  1. 2012 (3)
  2. 2010 (5)
  3. 2009 (2)
  4. 2008 (2)
  5. 2007 (1)
  6. 2006 (4)

More Years

Publications
  1. Cancer Research (14)
  2. Clinical Cancer Research (3)
  3. Cancer Cell (2)
  4. Cancer Discovery (1)
  5. EJC Supplements (1)
  6. Oncogene (1)

More Publications

Publishers
  1. American Association for Cancer Research (19)
  2. Cell Press (2)
  3. American Association for the Advancement of Science (1)
  4. Nature Publishing Group (1)
  5. Pergamon-Elsevier Science Ltd (1)
  6. Public Library of Science (1)

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Coexistent PI3K mutation in human tumors is associated with decreased dependency on mutant KRAS and MEK/ERK signaling for transformation
    Meeting Abstract

    Halilovic, E.; She, Q.; Ye, Q.; Solit, D. B.; Rosen, N.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Breast tumor cells with P13K mutation or HER2 amplification are selectively addicted to Akt signaling
    Journal Article

    She, Q. B.; Chandarlapaty, S.; Ye, Q.; Lobo, J.; Haskell, K. M.; Leander, K. R.; DeFeo-Jones, D.; Huber, H. E.; Rosen, N.
    PLoS ONE (2008)

    Fulltext@MSK | Save
  • The PI3K/AKT and MAPK signaling cooperate to mediate translational initiation and cell survival in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Zhen, W.; Solit, D.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of P13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • IGF-1 rescues rapamycin-induced cell growth inhibition
    Meeting Abstract

    O'reilly, K. E.; She, Q. B.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
    Journal Article

    O'reilly, K. E.; Rojo, F.; She, Q. B.; Solit, D.; Mills, G. B.; Smith, D.; Lane, H.; Hofmann, F.; Hicklin, D. J.; Ludwig, D. L.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3 kinase and EGFR overcomes the intrinsic apoptosis resistance of PTEN-null cancer cells and suppresses their xenograft growth
    Meeting Abstract

    She, Q. B.; Solit, D.; Ye, Q.; O'reilly, K.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The IGF-1 dependent feedback activation of AKT
    Meeting Abstract

    Oreilly, K. E.; She, Q. B.; Solit, D.; Lane, H.; Hofmann, F.; Hicklin, D. J.; Baselga, J.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save